infections, and changes in the L1 retrotransposon expression patterns in the
lung tissues of COVID-19
Tyurin, Anton V.,
Akhiyarova, Karina E.,
Valishin, Damir A.,
Sadretdinova, Lidiya D.,
Khusainova, Leonora N.,
Zagidullin, Naufal S.,
Gantseva, Khalida K.,
Pavlov, Valentin N. (2022) of
lung damage in all groups, compared with the baseline level. Conclusion — Tocilizumab in the form